Tag: Tumor

  • Nation & World

    Microdevices turn brain tumors into tiny labs

    A microdevice has been designed that can be implanted into tumors to conduct dozens of experiments at once to study the effects of new treatments on some of the hardest-to-treat brain cancers.

    4 minutes
    Pier Paolo Peruzzi (left) and Oliver Jonas.
  • Nation & World

    Tumor cells can prevent tumor spread

    A new study from Harvard-affiliated Beth Israel Deaconess Medical Center finds that a group of little-explored cells in the tumor microenvironment likely serves as an important gatekeeper against cancer progression and metastasis.

    5 minutes
  • Nation & World

    A data bank to battle cancer

    Researchers at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute are collaborating on a massive, long-term effort to collect and analyze tumor tissue from 10,000 cancer patients annually. The researchers hope the data will enable them to understand better how tumors behave, while providing opportunities to test new therapies.

    4 minutes
  • Nation & World

    Disrupting a cancer gene

    Scientists at Harvard-affiliated Dana-Farber Cancer Institute have successfully disrupted the function of a cancer gene involved in the formation of most human tumors by tampering with the gene’s “on” switch and growth signals, rather than targeting the gene itself.

    3 minutes
  • Nation & World

    Predicting cancer’s spread

    Harvard researchers at Dana-Farber Cancer Institute (DFCI) have identified a number of cancer genes that endow melanoma tumors with the ability to metastasize, making it possible to predict whether the tumors are likely to spread.

    5 minutes
  • Nation & World

    Critical finding for skin cancer treatment

    Researchers’ findings pinpoint a critical gene involved in melanoma growth, and provide a framework for discovering ways to tackle cancer drug resistance.

    5 minutes
  • Nation & World

    Better odds

    Test could predict which children with T-cell acute lymphoblastic leukemia are best candidates for clinical trials of new therapies, research finds.

    4 minutes